Researchers have developed a machine learning model using XGBoost to predict the risk of ESBL-producing Enterobacteriaceae before culture results are available. This model, trained on data from 12 hospitals, aims to guide empiric antibiotic selection, potentially reducing unnecessary carbapenem use and its associated resistance. The model achieved high negative predictive value, suggesting it could safely spare carbapenems in non-ICU settings. SHAP analysis indicated that prior ESBL colonization was the most significant predictor, with factors like neighborhood deprivation having minimal impact on performance. AI
IMPACT This model could improve antibiotic stewardship and combat antimicrobial resistance by enabling more precise empiric treatment decisions.
RANK_REASON The cluster contains a research paper detailing a new machine learning model for medical risk stratification. [lever_c_demoted from research: ic=1 ai=1.0]
- carbapenem antibiotic
- cefepime
- ceftazidime
- ceftriaxone
- Enterobacteriaceae
- PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
- Shap
- XGBoost
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →